Company intelligence / Profile preview

Primordial Genetics

San Diego, California, United States

Ownership: Private
Employees: ~7
Development stage: Other

Overview

Primordial Genetics (now operating as Primrose Bio) is a synthetic biology/platform company that engineers microbes, enzymes and protein expression systems for manufacturing RNA, DNA and complex biologics. Its technologies (Function Generator, Prima RNApols, Pelican/Pfenex Expression Technology and PeliCRM197) are licensed into multiple approved vaccines and biologics and are used by major pharma partners for biotherapeutic and vaccine manufacturing.[2][4][7][9][10]

Modalities: ProteinRecombinant proteinEnzymeSmall moleculeVaccinemRNA-based drugs
Industry: Non-Drug Biotech

Partnerships

MerckJazz PharmaceuticalsAlvogenSerum Institute of IndiaArcellxArcturus TherapeuticsVarious mRNA therapeutics companies

Beyond the preview

Go deeper on Primordial Genetics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primordial Genetics.

Explore the full profile